BRIEF-Redhill Biopharma says positive DSMB recommendation for continuation of RHB-104 Phase III study

* Redhill Biopharma announces positive and unanimous DSMB

recommendation for continuation of Phase III study with RHB-104

for Crohn's disease

Read more